160 related articles for article (PubMed ID: 10562705)
1. Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.
Zipp F; Krammer PH; Weller M
Immunol Today; 1999 Dec; 20(12):550-4. PubMed ID: 10562705
[No Abstract] [Full Text] [Related]
2. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95).
White CA; McCombe PA; Pender MP
Int Immunol; 1998 Jul; 10(7):935-41. PubMed ID: 9701031
[TBL] [Abstract][Full Text] [Related]
3. LRP1 expression in microglia is protective during CNS autoimmunity.
Chuang TY; Guo Y; Seki SM; Rosen AM; Johanson DM; Mandell JW; Lucchinetti CF; Gaultier A
Acta Neuropathol Commun; 2016 Jul; 4(1):68. PubMed ID: 27400748
[TBL] [Abstract][Full Text] [Related]
4. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.
White CA; McCombe PA; Pender MP
J Neuroimmunol; 1998 Feb; 82(1):47-55. PubMed ID: 9526845
[TBL] [Abstract][Full Text] [Related]
5. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
[TBL] [Abstract][Full Text] [Related]
6. CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2.
Zipp F; Faber E; Sommer N; Müller C; Dichgans J; Krammer PH; Martin R; Weller M
J Neuroimmunol; 1998 Jan; 81(1-2):168-72. PubMed ID: 9521618
[TBL] [Abstract][Full Text] [Related]
7. Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease.
Sabelko-Downes KA; Russell JH; Cross AH
J Neuroimmunol; 1999 Dec; 100(1-2):42-52. PubMed ID: 10695714
[TBL] [Abstract][Full Text] [Related]
8. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs.
Ishigami T; White CA; Pender MP
Eur J Immunol; 1998 May; 28(5):1626-35. PubMed ID: 9603469
[TBL] [Abstract][Full Text] [Related]
9. Role of microglia in autoimmune encephalomyelitis.
Matsumoto Y
Neuropathol Appl Neurobiol; 1994 Apr; 20(2):196-8. PubMed ID: 7521021
[No Abstract] [Full Text] [Related]
10. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
Kuerten S; Angelov DN
Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system.
Sabelko KA; Kelly KA; Nahm MH; Cross AH; Russell JH
J Immunol; 1997 Oct; 159(7):3096-9. PubMed ID: 9317103
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE.
Lake J; Weller RO; Phillips MJ; Needham M
J Pathol; 1999 Jan; 187(2):259-65. PubMed ID: 10365103
[TBL] [Abstract][Full Text] [Related]
13. Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Billetta R; Ghahramani N; Morrow O; Prakken B; de Jong H; Meschter C; Lanza P; Albani S
Clin Immunol; 2012 Nov; 145(2):94-101. PubMed ID: 22982294
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis.
Kohji T; Matsumoto Y
J Neuroimmunol; 2000 Jul; 106(1-2):165-71. PubMed ID: 10814794
[TBL] [Abstract][Full Text] [Related]
15. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.
Niculescu T; Weerth S; Niculescu F; Cudrici C; Rus V; Raine CS; Shin ML; Rus H
J Immunol; 2004 May; 172(9):5702-6. PubMed ID: 15100315
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of phospholipase D1 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Ahn M; Min DS; Kang J; Jung K; Shin T
Neurosci Lett; 2001 Dec; 316(2):95-8. PubMed ID: 11742724
[TBL] [Abstract][Full Text] [Related]
18. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
[TBL] [Abstract][Full Text] [Related]
19. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of microglial activity in brain and spinal cord in autoimmune encephalomyelitis.
Phillips M; Kida S; Steart PV; Iannotti F; Weller RO
Neuropathol Appl Neurobiol; 1994 Apr; 20(2):201-2. PubMed ID: 8072662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
